VN1R108P

Across TCGA pan-cancer cohorts, VN1R108P RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of VN1R108P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where VN1R108P RNA is repressed in tumor relative to normal tissue. In most cancer types VN1R108P is over-expressed in tumor, although a few such as THCA and BRCA show the opposite, repressed pattern.

THCA, BRCA, and KIRC are the cancer types where VN1R108P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in VN1R108P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	All	−0.858	<.001	9	view →
BRCA	Female	All	−0.390	<.001	6	view →
KIRC	All	II,III,IV	−0.309	.003	6	view →
LIHC	All	All	+0.164	<.001	5	view →
KIRP	All	IV	+0.937	<.001	4	view →
CHOL	All	All	+0.848	<.001	4	view →
BLCA	Female	All	+0.470	.033	3	view →
PAAD	Female	All	+0.640	.009	2	view →
KICH	All	All	−0.551	.004	2	view →
UCEC	All	All	−0.341	.042	2	view →
COAD	Male	All	+0.303	.020	2	view →
LUAD	All	III,IV	−0.291	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

VN1R108P–THCA

Open the THCA breakdown →